Extracellular vesicle proteins and their use for cancer diagnosis, predicting response to therapy, and treatment
US12163959B2 · kind B2 · utility
0Cited by
3References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 9, 2018 |
| Grant date | Dec 10, 2024 |
| Priority date | — |
| Expiry date | Jan 2, 2041 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/7028
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Compositions and methods are disclosed for treating cancer patients and identifying patients with a malignancy that are likely to respond to treatment with anti-PD-1/PD-L1 and other anti-cancer and immune-modulating therapeutics.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.